Evidence map›Paper›PMID 37005885›Full record

Trial reportJournal of Alzheimer's disease : JAD2023

Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer's Disease.

Farzaneh Rahmani, Laura Ghezzi, Valeria Tosti, Jingxia Liu, Sheng-Kwei Song, Anthony T Wu, Jayashree Rajamanickam, Kathleen A Obert, Tammie L S Benzinger, Bettina Mittendorfer and 2 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of Alzheimer's disease : JAD, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Nutrition as a systems regulator of brain aging trajectories.Frontiers in molecular neuroscience · 2026
    Review
  5. Review
  6. Time-restricted eating in Alzheimer's disease: TREAD pilot trial design.Contemporary clinical trials communications · 2025
    Article
  7. Review
  8. Article
  9. Neuroinflammation in Alzheimer disease.Nature reviews. Immunology · 2025
    Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Farzaneh RahmaniMallinckrodt Institute of Radiology, Division of Neuroradiology, Washington University in St. Louis, St. Louis, MO, USA.
Laura GhezziDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Valeria TostiDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Jingxia LiuMallinckrodt Institute of Radiology, Division of Neuroradiology, Washington University in St. Louis, St. Louis, MO, USA.
Sheng-Kwei SongDepartment of Physics, Washington University in St. Louis, St. Louis, MO, USA.
Anthony T WuDepartment of Physics, Washington University in St. Louis, St. Louis, MO, USA.
Jayashree RajamanickamMallinckrodt Institute of Radiology, Division of Neuroradiology, Washington University in St. Louis, St. Louis, MO, USA.
Kathleen A ObertDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Tammie L S BenzingerMallinckrodt Institute of Radiology, Division of Neuroradiology, Washington University in St. Louis, St. Louis, MO, USA.
Bettina MittendorferDepartment of Medicine, Division of Geriatrics and Nutritional Science, Washington University in St. Louis, St. Louis, MO, USA.
Laura PiccioDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Cyrus A RajiMallinckrodt Institute of Radiology, Division of Neuroradiology, Washington University in St. Louis, St. Louis, MO, USA.
Washington University in St. Louis · USMallinckrodt (United States) · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 1999 to 2026
$30.2M
Neuroinflammation and Alzheimer's Disease Imaging Biomarkers in Midlife ObesityRF1AG072637 · NIA · WASHINGTON UNIVERSITY · PI RAJI, CYRUS A · 2021 to 2021
$2.3M
Neuroinflammation and Alzheimer's Disease Imaging Biomarkers in Midlife ObesityR01AG072637 · NIA · WASHINGTON UNIVERSITY · PI RAJI, CYRUS A · 2024 to 2025
$1.4M
NCATS NIH HHS UL1 TR002345NIA NIH HHS R01 AG072637NIA NIH HHS RF1 AG072637NIDDK NIH HHS P30 DK056341
6 · The paper itself

Abstract

backgroundMultiple sclerosis (MS) is a prototype neuroinflammatory disorder with increasingly recognized role for neurodegeneration. Most first-line treatments cannot prevent the progression of neurodegeneration and the resultant disability. Interventions can improve symptoms of MS and might provide insights into the underlying pathology.

objectiveTo investigate the effect of intermittent caloric restriction on neuroimaging markers of MS.

methodsWe randomized ten participants with relapsing remitting MS to either a 12-week intermittent calorie restriction (iCR) diet (n = 5) or control (n = 5). Cortical thickness and volumes were measured through FreeSurfer, cortical perfusion was measured by arterial spin labeling and neuroinflammation through diffusion basis spectrum imaging.

resultsAfter 12 weeks of iCR, brain volume increased in the left superior and inferior parietal gyri (p: 0.050 and 0.049, respectively) and the banks of the superior temporal sulcus (p: 0.01). Similarly in the iCR group, cortical thickness improved in the bilateral medial orbitofrontal gyri (p: 0.04 and 0.05 in right and left, respectively), the left superior temporal gyrus (p: 0.03), and the frontal pole (p: 0.008) among others. Cerebral perfusion decreased in the bilateral fusiform gyri (p: 0.047 and 0.02 in right and left, respectively) and increased in the bilateral deep anterior white matter (p: 0.03 and 0.013 in right and left, respectively). Neuroinflammation, demonstrated through hindered and restricted water fractions (HF and RF), decreased in the left optic tract (HF p: 0.02), and the right extreme capsule (RF p: 0.007 and HF p: 0.003).

conclusionThese pilot data suggest therapeutic effects of iCR in improving cortical volume and thickness and mitigating neuroinflammation in midlife adults with MS.

Indexed as

Alzheimer DiseaseMultiple SclerosisBrainCaloric RestrictionHumansMagnetic Resonance ImagingNeuroinflammatory DiseasesPilot ProjectsAlzheimer’s diseasearterial spin labelingcaloric restrictiondiffusion basis spectrum imagingmultiple sclerosisneuroinflammationpreventionrelative cerebral blood flow

Identifiers

PMID37005885
PMCPMC10460547
OpenAlexW4361222887

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.